New guidelines provide direction on molecular testing for patients who could benefit from targeted lung cancer treatment.
Even when accounting for competing risks, data shows that patients with lung cancer who are HIV-infected have a worse prognosis than those who are noninfected.
For the subset of patients with non-small cell lung cancer who are ALK-positive, targeted therapy offers the potential for improved long-term outcome.
Patients can learn more about resources that can help them quit smoking in this informational fact sheet.
This patient information sheet addresses common questions about the harms of smokeless tobacco.
This fact sheets answers common questions patients may have about the link between cigar smoking and cancer.
This patient fact sheet contains information on the different types of tumors as well as an overview of available biomarker tests and personalized medicine.
Studies presented at the 15th World Conference on Lung Cancer reveal two new approaches to improving outcome in advanced-stage lung cancer.
Calcium, in particular, appears to have a protective benefit against lung cancer for some subgroups.
A coincidental finding may lead to a new method of diagnosing cancer in high-risk patients.
Mesothelioma has a very poor prognosis, but gene therapies may offer some hope for extended survival.
Patients need support and treatment to become tobacco-free and reduce their cancer risk.
This slideshow reviews Abraxane® (paclitaxel protein-bound particles (albumin-bound) for patients with non-small cell lung cancer.
Table of Contents
Slide 3: Indication, Dosage, ...
By Sandra Cuellar, PharmD, BCOP
A 63-year-old male is referred by his primary care physician for work-up of possible lung cancer. ...
By Tara Morrison, MD; Yu-Ning Wong, MD, MSCE
A 66-year-old African American man presented with a several month history of weight ...
More people in the United States die from lung cancer than any other type of cancer. This is true for ...
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|